Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: EN Paris
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Large Pharma

ABBV:FP

60.2500 EUR 0.7500 1.23%

As of 09:08:04 ET on 04/23/2015.

Snapshot for AbbVie Inc (ABBV)

Open: 60.2500 Day's Range: 60.2500 - 60.2500 Volume: 27
Previous Close: 61.0000 52wk Range: 38.3800 - 61.8000 1-Yr Rtn: -

Stock Chart for ABBV

No chart data available.
  • ABBV:FP 60.2500
  • 1D
  • 1M
  • 1Y
61.0000
Interactive ABBV Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for ABBV

Current P/E Ratio (ttm) -
Estimated P/E(12/2015) 15.5134
Relative P/E vs. CAC -
Earnings Per Share (USD) (ttm) -
Est. EPS (USD) (12/2015) 4.2360
Est. PEG Ratio 1.6287
Market Cap (M EUR) 95,940.43
Shares Outstanding (M) 1,592.37
30 Day Average Volume 71
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield 3.19%
Cash Dividend (USD) 0.5100
Dividend Ex-Date 04/13/2015
5 Year Dividend Growth -
Next Earnings Announcement 07/24/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for ABBV

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for ABBV

AbbVie Inc. researches and develops pharmaceutical products. The Company produces pharmaceutical drugs for specialty therapeutic areas such as immunology, chronic kidney disease, Hepatitis C, women's health, oncology, and neuroscience. AbbVie also offers treatments for diseases including Multiple Sclerosis, Parkinson's, and Alzheimer's disease.

Richard A Gonzalez "Rick"Chairman/CEOWilliam J ChaseExec VP/CFO
Michael E Severino "Mike"Exec VP:Research & DevelopmentLaura J SchumacherExec VP:Bus Dev/Secy /Gen Cnsl
More Company Profile & Key Executives for ABBV

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil